Seeking Solutions in Secondary Stroke Prevention: Insights on Factor XIa Inhibition

In this activity, experts discuss the potential role for Factor XIa inhibition in secondary stroke prevention following an acute non-cardioembolic ischemic stroke or high-risk transient ischaemic attack. For the complete activity, including supporting material, please visit: www.peervoice.com/FBM861. Presented by: Xin Cheng, MD, PhD, Ashkan Shoamanesh, MD, FRCPC, and Jeffrey Weitz, MD, OC, FRCP(C). Learning Objectives: Explain the rationale and potential role for Factor XIa inhibition in secondary prevention of non-cardioembolic ischaemic stroke (NCIS) or high-risk transient ischaemic attack (TIA); Recall the trial design, methodology, and inclusion criteria for key phase 3 trials of Factor XIa inhibitors in secondary stroke prevention (SSP) of NCIS or high-risk TIA; Evaluate clinical outcomes for Factor XIa inhibitors in the prevention of ischaemic stroke following an acute NCIS or high-risk TIA.